Med Ed Report briefs: May 2012

Share this article:
An image from the Septris game
An image from the Septris game

Sens. Charles Grassley (R-IA) and Herb Kohl (D-WI) requested that CMS complete a final Sunshine rule no later than this June, so that companies can start collecting data this year.

Software outfit Viscira launched a new Online Speaker Portal for clients, designed to serve as a communication hub for pharma product speakers, and let them access resources and tools for peer-to-peer educational talks.

CBI said it will hold its 10th Annual Forum on Educational Grants next September 11-12 in Philadelphia.

Stanford Medical School's CME program funded development of a web- and mobile-based game, called Septris (a la arcade classic Tetris), to teach doctors about treating the sepsis bacterial infection. The $30,000 grant for the game was part of Pfizer's three-year, $3 million grant to the school.

Only 22% of US certified CME now involves funding from a named brand, according to companies surveyed for a study by Cutting Edge Information. CME attendees now see industry affiliation as “tainting the CME material,” said Cutting Edge COO Adam Bianchi.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.